Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.
Sponsor:
Information provided by:
Baqiyatallah Medical Sciences University
ClinicalTrials.gov Identifier:
NCT00512811
First received: August 7, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure


Condition Intervention Phase
Bronchiolitis
Drug: furosemide
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Resource links provided by NLM:


Further study details as provided by Baqiyatallah Medical Sciences University:

Primary Outcome Measures:
  • effect of furosemid inhalation on dyspnea

  Eligibility

Ages Eligible for Study:   32 Years to 83 Years
Genders Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00512811

Locations
Iran, Islamic Republic of
RCCI
Tehran, Iran, Islamic Republic of
Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Investigators
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00512811     History of Changes
Other Study ID Numbers: 121a25
Study First Received: August 7, 2007
Last Updated: August 7, 2007
Health Authority: Iran: Ethics Committee

Keywords provided by Baqiyatallah Medical Sciences University:
furosemide
inhalation
dyspnea
spirometry
mustard gas
bronchiolitis
sulfur mustard

Additional relevant MeSH terms:
Bronchiolitis
Dyspnea
Respiratory Aspiration
Bronchial Diseases
Bronchitis
Lung Diseases
Lung Diseases, Obstructive
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Respiratory Tract Infections
Signs and Symptoms
Signs and Symptoms, Respiratory
Furosemide
Mustard Gas
Cardiovascular Agents
Dermatologic Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Therapeutic Uses

ClinicalTrials.gov processed this record on November 24, 2014